Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 18 studies | 26% ± 11% | |
classical monocyte | 10 studies | 24% ± 7% | |
ciliated cell | 9 studies | 28% ± 10% | |
adipocyte | 9 studies | 26% ± 8% | |
macrophage | 9 studies | 22% ± 6% | |
endothelial cell | 7 studies | 24% ± 5% | |
alveolar macrophage | 7 studies | 25% ± 6% | |
non-classical monocyte | 6 studies | 20% ± 5% | |
pericyte | 6 studies | 20% ± 6% | |
monocyte | 5 studies | 18% ± 3% | |
epithelial cell | 5 studies | 33% ± 12% | |
myofibroblast cell | 4 studies | 19% ± 3% | |
GABAergic neuron | 4 studies | 39% ± 13% | |
astrocyte | 4 studies | 22% ± 5% | |
glutamatergic neuron | 4 studies | 42% ± 15% | |
oligodendrocyte | 4 studies | 18% ± 2% | |
conventional dendritic cell | 3 studies | 19% ± 2% | |
hematopoietic precursor cell | 3 studies | 19% ± 3% | |
myeloid cell | 3 studies | 19% ± 4% | |
endothelial cell of lymphatic vessel | 3 studies | 22% ± 4% | |
muscle cell | 3 studies | 22% ± 2% | |
type I pneumocyte | 3 studies | 18% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 7% | |
basal cell | 3 studies | 33% ± 7% | |
goblet cell | 3 studies | 27% ± 10% | |
neuron | 3 studies | 28% ± 9% | |
connective tissue cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1416.66 | 578 / 578 | 100% | 7.26 | 1152 / 1155 |
esophagus | 100% | 1000.16 | 1444 / 1445 | 99% | 6.75 | 182 / 183 |
brain | 99% | 930.69 | 2621 / 2642 | 100% | 8.83 | 705 / 705 |
breast | 100% | 1541.88 | 459 / 459 | 99% | 9.29 | 1105 / 1118 |
ovary | 100% | 1051.03 | 180 / 180 | 99% | 6.42 | 425 / 430 |
uterus | 100% | 1133.97 | 170 / 170 | 98% | 6.88 | 449 / 459 |
prostate | 100% | 1113.12 | 245 / 245 | 98% | 8.40 | 491 / 502 |
pancreas | 100% | 629.69 | 327 / 328 | 98% | 6.56 | 174 / 178 |
stomach | 100% | 853.69 | 359 / 359 | 97% | 6.62 | 278 / 286 |
intestine | 100% | 983.23 | 966 / 966 | 96% | 6.20 | 508 / 527 |
bladder | 100% | 1076.48 | 21 / 21 | 95% | 5.84 | 478 / 504 |
thymus | 100% | 1115.78 | 653 / 653 | 95% | 6.31 | 573 / 605 |
skin | 100% | 1677.60 | 1806 / 1809 | 94% | 8.66 | 444 / 472 |
kidney | 100% | 1021.47 | 89 / 89 | 91% | 5.18 | 816 / 901 |
adrenal gland | 100% | 1131.82 | 258 / 258 | 87% | 5.94 | 201 / 230 |
liver | 93% | 472.35 | 211 / 226 | 79% | 3.49 | 319 / 406 |
adipose | 100% | 1790.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1295.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 637.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.84 | 45 / 45 |
muscle | 100% | 837.97 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 682.49 | 806 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 808.70 | 838 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.28 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 68% | 3.14 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0044565 | Biological process | dendritic cell proliferation |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0097028 | Biological process | dendritic cell differentiation |
GO_0042110 | Biological process | T cell activation |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_1902554 | Cellular component | serine/threonine protein kinase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | AZI2 |
Protein name | 5-azacytidine induced 2 5-azacytidine-induced protein 2 5-azacytidine-induced protein 2 (NF-kappa-B-activating kinase-associated protein 1) (Nak-associated protein 1) (Nap1) (TILP) |
Synonyms | NAP1 TBKBP2 |
Description | FUNCTION: Adapter protein which binds TBK1 and IKBKE playing a role in antiviral innate immunity . Activates serine/threonine-protein kinase TBK1 and facilitates its oligomerization . Enhances the phosphorylation of NF-kappa-B p65 subunit RELA by TBK1 . Promotes TBK1-induced as well as TNF-alpha or PMA-induced activation of NF-kappa-B . Participates in IFNB promoter activation via TICAM1 . . |
Accessions | ENST00000429369.5 ENST00000420543.6 [Q9H6S1-4] ENST00000457172.5 [Q9H6S1-4] ENST00000414162.5 Q9H6S1 ENST00000334100.10 [Q9H6S1-5] ENST00000415852.1 C9JVK8 H7C1Z1 C9JGA2 ENST00000479665.6 [Q9H6S1-1] |